(917) 310-3371
Current insurance information
Bring the medical and pharmacy cards, member details, and any separate pharmacy-benefit information.
PCOS, PMOS, and GLP-1 insurance coverage
Separate visit coverage, weight-management eligibility, prescription benefits, and prior authorization before treatment.
PMOS or PCOS can be important clinical context, but it does not guarantee that a health plan covers Wegovy, Zepbound, Saxenda, or another weight-management medicine. The prescribed product must match the diagnosis, benefit, and plan rules.
Coverage is a sequence of checks
Confirm the visit benefit, weight-management drug benefit, labeled eligibility, preferred product, prior authorization, pharmacy network, quantity limits, copay, and renewal requirements.
Important distinction: Nao Medical accepts Medicaid and many major insurance plans, but no plan or medication is guaranteed. PCOS or PMOS should not be described as an automatic coverage diagnosis for a GLP-1-based weight-management medicine. GLP-1-based obesity medicines are not FDA approved to treat PMOS or PCOS itself.
Why coverage questions need to be separated
A single insurance card can contain different rules for office care, laboratory testing, counseling, nutrition, and prescription medication.
Office-visit benefit
Confirm whether the medical weight-loss or women's-health evaluation is in network and whether referral, copay, or deductible rules apply.
Weight-loss medication benefit
Some plans cover obesity medicines, some exclude them, and some cover only selected products after authorization.
Labeled eligibility
Documentation should support the medicine's current indication rather than relying on PCOS or PMOS as a substitute diagnosis.
Preferred product
The plan may prefer one brand, require a trial of another treatment, or change its formulary during the year.
Pharmacy pathway
Specialty, retail, mail-order, network, quantity, and availability rules can affect where and when the medicine is filled.
Renewal requirements
Continued coverage may require follow-up, response documentation, adherence, updated weight or health data, and a new authorization.
What to collect before authorization
Complete records reduce avoidable delays, but accurate documentation cannot guarantee approval when a benefit excludes the medicine.
Weight and health history
Document current and prior weight data, weight-related conditions, relevant labs, and the clinical reason for treatment.
Prior treatment
List nutrition, activity, behavioral, medication, or program history when the plan requests prior weight-management efforts.
Previous denials
Bring denial letters, case numbers, requested records, appeal deadlines, and prior authorization decisions.
Correct product and diagnosis
Use a medicine and brand that match the intended FDA indication. Diabetes brands are not automatic substitutes for obesity products.
Pregnancy and contraception plan
Coverage work does not replace the reproductive safety review required before GLP-1-based treatment.
Safety and care boundaries
- Do not buy, compound, borrow, or substitute a medicine because an insurance request is delayed or denied without a clinician and licensed pharmacy confirming the product and plan.
- Do not use a diabetes diagnosis, medication brand, or PMOS or PCOS code inaccurately to obtain coverage.
- A denial can reflect a benefit exclusion rather than a judgment that the clinical concern is unimportant.
- Self-pay cost can change by product, dose, pharmacy, manufacturer program, and supply. Confirm the full recurring cost before starting long-term treatment.
- Medication safety, pregnancy planning, and monitoring requirements remain the same whether insurance, self-pay, or a manufacturer program is used.
What happens during evaluation and follow-up
1. Verify benefits
Check the office visit and prescription benefit separately, including preferred products and exclusions.
2. Complete evaluation
Document the diagnosis, current indication, health history, prior treatment, and safety review before requesting a medicine.
3. Submit accurate records
Provide the requested clinical notes, laboratory information, and prior authorization forms without overstating PMOS or PCOS as an approved drug indication.
4. Plan the outcome
If approved, confirm pharmacy and follow-up. If denied, review the reason, appeal options, covered alternatives, and safe next steps.
Start in NYC or Long Island
Book the existing medical weight-loss evaluation. The care team will confirm whether the first visit is virtual or in person and whether women's-health or specialist coordination is also needed.
Bronx
174th Street
932 E 174th St, Bronx, NY 10460
Bring insurance, pharmacy-benefit, prior authorization, and PMOS or PCOS records to the weight-management evaluation. The scheduling team will confirm the right visit type and current clinic availability.
Queens
Astoria
37-15 23rd Ave, Astoria, NY 11105
Bring insurance, pharmacy-benefit, prior authorization, and PMOS or PCOS records to the weight-management evaluation. The scheduling team will confirm the right visit type and current clinic availability.
Bronx
Bartow Mall
2063A Bartow Ave, Bronx, NY 10475
Bring insurance, pharmacy-benefit, prior authorization, and PMOS or PCOS records to the weight-management evaluation. The scheduling team will confirm the right visit type and current clinic availability.
Brooklyn
Crown Heights
341 Eastern Pkwy, Brooklyn, NY 11216
Bring insurance, pharmacy-benefit, prior authorization, and PMOS or PCOS records to the weight-management evaluation. The scheduling team will confirm the right visit type and current clinic availability.
Long Island
Hicksville
232 W Old Country Rd, Hicksville, NY 11801
Bring insurance, pharmacy-benefit, prior authorization, and PMOS or PCOS records to the weight-management evaluation. The scheduling team will confirm the right visit type and current clinic availability.
Queens
Jackson Heights
80-10 Northern Blvd, Jackson Heights, NY 11372
Bring insurance, pharmacy-benefit, prior authorization, and PMOS or PCOS records to the weight-management evaluation. The scheduling team will confirm the right visit type and current clinic availability.
Queens
Jamaica
90-18 Sutphin Blvd, Jamaica, NY 11435
Bring insurance, pharmacy-benefit, prior authorization, and PMOS or PCOS records to the weight-management evaluation. The scheduling team will confirm the right visit type and current clinic availability.
Queens
Long Island City
30-07 36th Ave, Astoria, NY 11106
Bring insurance, pharmacy-benefit, prior authorization, and PMOS or PCOS records to the weight-management evaluation. The scheduling team will confirm the right visit type and current clinic availability.
Long Island
Mineola
135 Mineola Blvd, Mineola, NY 11501
Bring insurance, pharmacy-benefit, prior authorization, and PMOS or PCOS records to the weight-management evaluation. The scheduling team will confirm the right visit type and current clinic availability.
Manhattan
StuyTown
259 1st Ave, New York, NY 10003
Bring insurance, pharmacy-benefit, prior authorization, and PMOS or PCOS records to the weight-management evaluation. The scheduling team will confirm the right visit type and current clinic availability.
Brooklyn
Williamsburg
308 Graham Ave, Brooklyn, NY 11211
Bring insurance, pharmacy-benefit, prior authorization, and PMOS or PCOS records to the weight-management evaluation. The scheduling team will confirm the right visit type and current clinic availability.
Related PMOS, PCOS, and weight-management care
PMOS and PCOS weight management
Coordinate weight, metabolic health, reproductive goals, and long-term follow-up.
GLP-1 eligibility
Review general obesity-treatment criteria, safety, and whether a labeled product fits.
Metformin compared with GLP-1
Compare different medication roles for metabolic and weight-management goals.
Pregnancy planning
Coordinate contraception, preconception timing, and treatment transitions.
Medical weight loss
Review Nao Medical's broader evaluation and monitoring program.
Wegovy insurance guidance
Review Nao Medical's existing Wegovy coverage resource.
Zepbound insurance guidance
Review Nao Medical's Zepbound coverage guidance.
Frequently asked questions
Coverage varies. PMOS or PCOS alone may not satisfy a weight-loss medication benefit. The plan may require obesity or overweight plus a qualifying condition, prior authorization, and a covered product.
Nao Medical accepts Medicaid and many major insurance plans. The office visit and prescription benefit are separate, and Medicaid managed-care formularies can differ.
No. Prior authorization submits the clinical and benefit information the plan requests. Approval still depends on coverage, eligibility, documentation, preferred products, and plan rules.
The clinician can review the denial or exclusion, medically appropriate covered alternatives, appeal options when applicable, and whether self-pay is realistic. Do not substitute another brand without a new clinical review.
A plan may consider PMOS or PCOS clinically relevant, but it should not be assumed to meet every label or payer definition. The clinician and plan must interpret the current criteria.
Those brands are approved for type 2 diabetes. They should not be prescribed or billed as shortcuts when the patient does not have the indicated diagnosis.
Bring the denial letter, pharmacy message, authorization number, insurance cards, prior treatment records, relevant diagnoses and labs, and any deadline for appeal or resubmission.
Official sources
Current guidelines and prescribing information define the evidence, approved uses, and safety boundaries. They do not determine whether a medicine is appropriate for an individual patient.
- FDA Wegovy prescribing information: Current approved uses and safety requirements that support accurate authorization documentation.
- FDA Zepbound prescribing information: Current approved uses and safety requirements for tirzepatide.
- FDA Saxenda prescribing information: Current approved uses and safety requirements for liraglutide.
- FDA Zepbound approval announcement: General adult chronic weight-management eligibility framework at approval.
- 2023 International Evidence-based Guideline: PMOS or PCOS guidance does not replace the medicine-specific indication or payer rules.
Health information notice
General information only. The information here is not medical advice and does not replace diagnosis, treatment, or guidance from a licensed clinician.
Content was updated August 2, 2026 from the cited sources and Nao Medical's current service information. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.